Ultrasound agent shows the elusive left ventricle
This article was originally published in Clinica
Phase III trials of DuPont Merck's second-generation contrast agent for cardiac ultrasound imaging have shown encouraging results in imaging the heart's left ventricle, the most difficult part of the organ to image with ultrasound.
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.